COVID-19 vaccines by Sinopharm on display at a trade fair in Beijing. AP/ File
Cayetano Heredia University, which is involved with the study, said that it did not know if the volunteer had received the vaccine or the placebo in the double blind trial A volunteer in the local Peruvian trial of a coronavirus vaccine produced by China’s Sinopharm Group Co Ltd has died from COVID-19 related pneumonia, the university carrying out the trial said on Tuesday.
Cayetano Heredia University, which is involved with the study, said that it did not know if the volunteer had received the vaccine or the placebo in the double blind trial. Peru is being hit by a second wave of COVID-19 infections.
Over 20 lakh healthcare workers across the country have received COVID-19 vaccine jabs till Tuesday evening, as per provisional reports, the Union health ministry has said.According to Health ministry
CHINA / DIPLOMACY By Global Times Published: Jan 27, 2021 06:54 PM
A nurse administers the second dose of COVID-19 vaccine to a driver of the Shenzhen Bus Group Co., Ltd. at the health service center of the Xiameilin community in Futian District, Shenzhen, south China s Guangdong Province, Jan. 24, 2021. The Shenzhen Bus Group Co., Ltd. encourages its employees to receive COVID-19 vaccines. (Xinhua/Mao Siqian)
A local volunteer in Peru participating in Chinese firm Sinopharm s COVID-19 vaccine clinical trials, who died of COVID-19 pneumonia, received a placebo, not the vaccine. A source close to Sinopharm told the Global Times there is no evidence that the death was related to the company s vaccine.